Casey Bourque
Family · Scottsdale, AZNPI 1508482902
Payments from drug & device makers
Across 95 payments — averaging $65.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$4K
- AbbVie$624
- AstraZeneca$253
- Revance Therapeutics, Inc.$244
- Novo Nordisk$188
- Boehringer Ingelheim$83
- plus $581 from 22 others
What the payments were for
- Consulting fees$2,52040%
- Travel & lodging$1,08917%
- Food & beverage$2,62942%
- Education$300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 10 | $4,295 |
| AbbVie(2 entities) | 25 | $624 |
| AstraZeneca | 10 | $253 |
| Revance Therapeutics, Inc. | 4 | $244 |
| Novo Nordisk | 6 | $188 |
| Boehringer Ingelheim | 4 | $83 |
| Lilly USA, LLC | 6 | $83 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $79 |
| Boston Scientific | 3 | $52 |
| Johnson & Johnson | 2 | $44 |
| Amgen | 3 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $18 |
| Organon | 1 | $17 |
| Alfasigma USA, Inc. | 1 | $17 |
| Phadia US Inc. | 1 | $16 |
| Bardy Diagnostics, Inc. | 1 | $15 |
| Merck | 1 | $14 |
| Seqirus USA Inc | 1 | $14 |
| Vistapharm, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Hologic Sales And Service, LLC | 1 | $13 |
| GSK | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,268 in reported general payments places this provider in the 90th percentile of 4,119 family providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 221 | $8,740 |
| Fluticasone Propionate | 113 | $1,698 |
| Famotidine | 91 | $1,080 |
| Methylprednisolone | 78 | $601 |
| Pantoprazole Sodium | 39 | $377 |
| Ciprofloxacin Hcl | 42 | $374 |
| Omeprazole | 36 | $286 |
| Dexamethasone | 17 | $221 |
| Montelukast Sodium | 23 | $203 |
| Meclizine Hcl | 11 | $85 |
| Triamcinolone Acetonide | 18 | $44 |
| Prednisone | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other family in Scottsdale
- Kaitlyn LouchheimScottsdale$208K
- Jennifer PrinceScottsdale$76K
- Camilla BinksScottsdale$62K
- Jessica TapiaScottsdale$36K
- Dawn MougelScottsdale$34K
- Keegan RussellScottsdale$28K
- Jamie HowardScottsdale$14K
- Anna CramerScottsdale$14K
- Sharon MagalonaMesa$449K
- Angela GoldenMunds Park$378K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.